文献速递青光眼

VIP通过VPAC2受体调控慢性高眼压模型大鼠Schlemm管形态与F-肌动蛋白分布

VIP Regulates Morphology and F-Actin Distribution of Schlemm's Canal in a Chronic Intraocular Pressure Hypertension Model via the VPAC2 Receptor.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2018-01-01

该研究在大鼠巩膜外静脉烧灼(EVC)慢性高眼压模型中,局部给予VIP或VPAC2拮抗剂PG99-465,发现VIP经VPAC2受体维持Schlemm管内皮细胞F-肌动蛋白正常分布、扩张塌陷的Schlemm管并显著降低眼压。体外HUVECs在压力刺激30分钟时F-肌动蛋白/G-肌动蛋白比值显著升高,50 μM VIP有助于维持该比值正常。VIP可能成为抗青光眼药物新靶点。

要点

  • EVC慢性高眼压大鼠Schlemm管内皮细胞VIP与VPAC2受体表达升高且F-肌动蛋白分布紊乱。
  • 局部VIP可维持Schlemm管内皮细胞F-肌动蛋白正常分布、扩张塌陷的Schlemm管并显著降低眼压。
  • 体外压力刺激30分钟使HUVECs的F-肌动蛋白/G-肌动蛋白比值显著升高,50 μM VIP有助于维持该比值正常。

核心结论

  • VIP通过VPAC2受体调控Schlemm管内皮细胞F-肌动蛋白分布,从而降低眼压。
  • VIP可能成为抗青光眼药物的新靶点。

研究设计与样本

  • 研究采用大鼠EVC慢性高眼压模型,局部给予VIP或VPAC2拮抗剂PG99-465。
  • 用Tono-Pen测量眼压,用HE和CD31免疫组化评估Schlemm管横截面积、周长和长度,用免疫荧光检测Schlemm管F-肌动蛋白分布。
  • 体外用压力系统处理HUVECs,通过免疫荧光和Western blotting研究F-肌动蛋白与G-肌动蛋白分布。

主要发现

  • EVC模型Schlemm管内皮细胞中VIP和VPAC2受体表达升高,F-肌动蛋白分布紊乱。
  • 局部VIP维持Schlemm管内皮细胞F-肌动蛋白正常分布、扩张塌陷的Schlemm管并显著降低EVC模型眼压。
  • 体外HUVECs在压力刺激30分钟时F-肌动蛋白/G-肌动蛋白比值显著升高,50 μM VIP有助于维持该比值正常。

关键数值与推荐

  • 体外HUVECs压力刺激30分钟使F-肌动蛋白/G-肌动蛋白比值显著升高。
  • 50 μM VIP有助于维持HUVECs在压力刺激下的正常F-肌动蛋白/G-肌动蛋白比值。

临床怎么用

  • VIP-VPAC2受体通路可能作为青光眼降眼压治疗的潜在新靶点。
  • Schlemm管内皮细胞F-肌动蛋白分布可作为评估降眼压干预的细胞学指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the roles of vasoactive intestinal peptides (VIPs) in regulating the morphology and F-actin distribution of Schlemm's canal (SC) of rat eyes. METHODS: Chronic intraocular pressure (IOP) hypertension models with episcleral venous cauterization (EVC) were treated with topical VIP or PG99-465 (vasoactive intestinal peptide receptors 2 [VPAC2] antagonist). IOPs were measured with Tono-Pen, and the SC parameters, including the cross-section area, circumference, and length, were statistically evaluated by hematoxylin-eosin and CD31 immunohistochemical staining. Immunofluorescence was performed to detect the distribution of F-actin in the SC. Moreover, the distribution of filamentous actin (F-actin) and globular actin (G-actin) in human umbilical vein endothelial cells (HUVECs) was studied under a pressure system by immunofluorescence and Western blotting. RESULTS: Increased expressions of VIP and VPAC2 receptors, as well as a disordered distribution of F-actin were found in SC endothelial cells (SCEs) in the EVC model. Moreover, topical VIP maintained the normal distribution of F-actin in SCEs, expanded the collapsed SC, and induced a significant decrease in IOP in the EVC model. In in vitro HUVECs, the F-actin/G-actin ratio increased significantly under stress stimulation for 30 minutes. A total of 50 μM VIP helped maintain the normal F-actin/G-actin ratio of HUVECs against stress stimulation. CONCLUSIONS: VIP regulates the distribution of F-actin in SCEs via the VPAC2 receptor in order to induce a decrease in IOP. VIP may represent a new target for antiglaucoma drugs.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Chen L, Li M, Luo Z, et al. VIP Regulates Morphology and F-Actin Distribution of Schlemm's Canal in a Chronic Intraocular Pressure Hypertension Model via the VPAC2 Receptor. Invest Ophthalmol Vis Sci. 2018. PMID: 30025111. doi:10.1167/iovs.17-22688

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。